RDA Medical Reimbursement Audit Questioned
A senior officer of the Rawalpindi Development Authority was reimbursed for medicines purchased in 2026 against a medical prescription issued in 2022, in apparent violation of the rules. The payment has raised questions about the professional responsibilities of the authority’s internal audit and finance directorate.
The RDA medical reimbursement case is small in money terms. The bill was Rs31,980. It matters because of the chain of failures around it. Every check that should have stopped the payment appears to have cleared it instead.
The prescription in question dates back to 2022, when the officer concerned was not posted at the RDA. The private hospital that issued the prescription is also not included on the authority’s approved list. The prescription included multivitamin medicines generally considered strength supplements rather than medicines for treating a specific illness.
Despite all that, medicines were purchased in 2026 against the 2022 prescription for the officer’s father, and the officer obtained reimbursement of Rs31,980 from the RDA. The medical reimbursement bill was approved by the RDA’s deputy director finance and director finance, while the authority’s internal audit also cleared it.
The RDA medical reimbursement case: four red flags
Each detail in the case points to a separate control that should have applied. A prescription from a year when the officer did not work at the authority should have raised a question about eligibility. A hospital outside the approved list should have raised a question about where treatment was obtained. Supplements, rather than medicines for a named illness, should have raised a question about what the money was actually for. A four-year gap between prescription and purchase should have raised a question about why the claim was made now.
None of those questions stopped the bill. It passed the deputy director finance, the director finance, and internal audit. That is the core of the story. A single error by one officer is a mistake. Clearance by three separate checkpoints suggests the system for checking claims is not working as it should.
The contrast with ordinary staff makes the case sharper. Subordinate employees and other officers of the RDA routinely face difficulties in obtaining reimbursement for their own medical treatment claims. The same system that delays routine claims cleared this one, even though it carried four obvious problems. Readers in Rawalpindi will understand why that contrast matters. It is not only about Rs31,980. It is about whether the rules apply evenly to senior officers and junior staff.
A history the audit must answer
This is not the first time the RDA’s financial controls have come under question. Previously, more than Rs2 billion had been transferred from the RDA’s official account to private firms and individuals through cash deposit receipts over a period of five to six years. At the time, the authority’s internal audit forum, director general, and director finance had also failed to prevent or trace those transactions.
The two cases are different in scale, but they share a pattern. Money moved, the checks that should have caught it did not, and the failure was discovered later rather than prevented at the time. The Rs2 billion case shows what weak controls can cost over time. The Rs31,980 case shows that the same weakness is still visible in a single, simple claim.
Leadership is part of that picture. The RDA currently has no full-time director general, with the Rawalpindi commissioner holding the additional charge of the post. An authority without a full-time head relies even more on its finance and audit officers to hold the line. In this case, those officers cleared the bill.
The authority’s response so far
Repeated attempts were made to obtain the RDA’s version regarding the payment. When contacted, Public Relations Officer Hafiz Mohammad Irfan requested that the news not be published. When pressed for the authority’s position, he asked for a formal questionnaire, which was duly sent. Despite waiting a day and contacting him again the following day, the PRO declined to comment on the matter and stopped answering calls.
That response leaves the key questions unanswered. Who checked the prescription date against the officer’s posting record. Who checked the hospital against the approved list. Who decided that supplements qualified for reimbursement. And what action, if any, will follow now that the payment is public.
